Coyote Bioscience is dedicated to innovation in portability of point-of-care molecular diagnostics, pathogen detection and Life Science Tools.

In 2013, Coyote Bioscience achieved its break-through One-Step molecular diagnostic method based on direct qPCR. No DNA extraction is required. Coyote's point-of-care technologies are designed to enable medical providers to identify disease early, enhancing the probability of patient's recovery and quality of life.

Coyote is committed to developing high quality products that meet our customer's needs and exceed their expectations. Quality is at the forefront of what we do from beginning to end, from the start of design through delivery of a product to our customer. We comply with applicable regulatory requirements and employ a meticulous quality management system. Coyote products have been and will be designed for portable, POC, environmental, agricultural and research testing.


Coyote Bioscience(Yixing)Co., Ltd was founded in October, 2014. It is located in Yixing Economic&Technological Development Zone, which cover the whole Yangtze River delta; The factory covers about 8000 square meters, including 3400 square meter electronics manufacturing zone and 1500 square meter GMP IVD reagent manufacturing workshop. Coyote Bioscience (Yixing) Co., Ltd is the manufacturing site for coyote instrument and reagent.


Coyote Bioscience USA was founded in 2015. It is located at the core area in San Francisco USA. It covers about 1500 square meters. It has establish cooperation relationship with top research center in USA. Coyote Bioscience USA is the R&D center for Coyote, focusing on the frontier product research and sales marketing for the US market.


Coyote Clinical diagnoistics Co., ltd started operation in August, 2016. It covers about 2000 square meters, including 1200 square meters clear room with Class 200K. It offers diagnostics services to medical institute and individual user. Based on coyote diagnositics platform, we can offer full solution for individualized health management such as infectious disease screening, cancer screening, genotyping diagnostics.
Milestone
2009
Coyote was founded
Release of H2O3 series lab temperature control product.
Current market share in Beijing is higher than 50%.
2010
New product debut: Theater PCR,the slimmest portable PCR among the world.
2013
New product debut:Mini8, the first portable Realtime PCR system in the world. New Technology:one-step reagent technology, without DNA/RNA extraction. PCT patent with the one-step reagent technology.
2014
Won first round 30 million RMB investment from SAIF Partners. Set up Coyote Bioscience (YIXING) Co., Ltd, as the manufacturing site for IVD reagent and instruments. Acquired Medical equipment manufacturing permit Listed as ODM supplier for Thermofisher.
2015
Coyote “one-step” Nucleic acid detection platform was used for field test to detect epidemic disease. Mini8 was listed by WHO for Ebola virus detection, as the first Chinese molecular diagnostics platform for Ebola virus detection. Won second round 80 million RMB joint investment from No...
2016
Successfully developed Zika Virus Detection Kit. Coyote Zika Virus Detection platform was used extensively in Entry-exit Inspection & Quarantine of the People’s Republic of China(CCIQ). One-step Zika Virus Detection reagent became the first Coyote One-step reagent won CFDA clearance. Min...
 
Up to Now, Coyote has 13 China patents and 28 PCT pending international patents.
Coyote was accredit as “Beijing Municipal International Cooperation Base for Molecular Diagnostics and Precision Medication” in 2016.
Coyote was accredit as “Enterprise Academic Workstation”. In 2015.
Coyote was listed as “China National Hi-tech Enterprise”
Coyote Bioscience Co., Ltd.

Phone: +8610 64844237
Coyote Bioscience USA Inc.
1506 Dell Avenue, Suite A, Campbell, CA 95008
Phone: +1 650-528-2199
Scan the QRcode
follow Coyotebio
Copyright 2017 . Coyote Bioscience Co., Ltd All rights reserved.